Thomas Leggett Black Diamond Therapeutics, Inc. (BDTX) insider trading activity
Thomas Leggett is Chief Financial Officer of Black Diamond Therapeutics, Inc.. Currently has a direct ownership of 0 shares of BDTX, which is worth approximately $0. The most recent transaction as insider was on Jan 08, 2021, when has been sold 3,000 shares (Common Stock) at a price of $33.94 per share, resulting in proceeds of $101,820. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
Thomas Leggett Transaction History
Also insider at
TL
Thomas Leggett
Chief Financial Officer
Cambridge, MA